Cargando…
Huperzine A for treatment of cognitive impairment in major depressive disorder: a systematic review of randomized controlled trials
BACKGROUND: Acetylcholinesterase (AChE) inhibitors have been shown to be effective in treating cognitive impairment in animal models and in human subjects with major depressive disorder (MDD). Huperzine A (HupA), a Traditional Chinese Medicine derived from a genus of clubmosses known as Huperzineser...
Autores principales: | ZHENG, Wei, XIANG, Ying-Qiang, UNGVARI, Gabor S., CHIU, F.K. Helen, H. NG, Chee, WANG, Ying, XIANG, Yu-Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shanghai Municipal Bureau of Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004090/ https://www.ncbi.nlm.nih.gov/pubmed/27605862 http://dx.doi.org/10.11919/j.issn.1002-0829.216003 |
Ejemplares similares
-
Electroconvulsive Therapy for Agitation in Schizophrenia: Metaanalysis of Randomized Controlled Trials
por: UNGVARI, Gabor S., et al.
Publicado: (2017) -
Adjunctive Melatonin for Tardive Dyskinesia in Patients with Schizophrenia: A Meta-Analysis
por: NG, Chee H., et al.
Publicado: (2017) -
Meta-analysis of the Efficacy and Safety of Adjunctive Rosuvastatin for Dyslipidemia in Patients with Schizophrenia
por: UNGVARI, Gabor S., et al.
Publicado: (2018) -
Effect of Cognitive Behavioral Therapy Versus Interpersonal Psychotherapy in Patients with Major Depressive Disorder: A Meta-analysis of Randomized Controlled Trials
por: Zhou, She-Gang, et al.
Publicado: (2017) -
Association of chronic obstructive pulmonary disease with mild cognitive impairment and dementia risk: A systematic review and meta-analysis
por: Zhao, Li-Ying, et al.
Publicado: (2022)